Abeona Therapeutics Inc Warrant
ABEOW
ABEOW was delisted on the 20th of December, 2019.
0 hedge funds and large institutions have $0 invested in Abeona Therapeutics Inc Warrant in 2019 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, reducing their positions, and 4 closing their positions.
100% less funds holding
Funds holding: 4 → 0 (-4)
100% less capital invested
Capital invested by funds: $215K → $0 (-$215K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$145K |
| 2 |
HCM
Highbridge Capital Management
New York
|
-$69K |
| 3 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$1K |
ABEOW Hedge Fund Activity: Q4 2019 in Review
0 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics Inc Warrant (ABEOW) for Q4 2019, worth a combined $0 — down 100% from $215K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of ABEOW and 0 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Perceptive Advisors, exiting entirely with an estimated $145K sold.
- 0 institutional investors held Abeona Therapeutics Inc Warrant (ABEOW) as of Q4 2019, down from 4 in Q3 2019.
- Funds reported $0 of Abeona Therapeutics Inc Warrant stock for Q4 2019, down 100% quarter-over-quarter.
- 0 funds opened new Abeona Therapeutics Inc Warrant positions in Q4 2019 and 4 closed out, a net change of -4 holders.
- The largest Abeona Therapeutics Inc Warrant seller in Q4 2019 was Perceptive Advisors, an estimated $145K sold.
Based on aggregated 13F filings for Q4 2019.